Company Filing History:
Years Active: 2004
Title: Søren Østergaard: Innovator in Diagnostic Methods
Introduction
Søren Østergaard is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of diagnostics, particularly in relation to borreliosis. His innovative work has led to the development of a patented method that utilizes specific peptide fragments for diagnostic purposes.
Latest Patents
Søren Østergaard holds a patent for "Osp-C derived peptide fragments." This diagnostic method utilizes short C-terminal fragments of the sensu lato derived protein OspC. The essential amino-terminal acids Pro-Lys-Pro (SEQ ID NO: 22) play a crucial role in immune reactivity between sera from patients suffering from early borreliosis and various OspC derivatives. The patent also highlights that for effective diagnostic agents, a homologue of a fragment identical to the 10 C-terminal amino acids of OspC (SEQ ID NO: 1) must be five consecutive amino acid residues long. Additionally, the patent discloses vaccines that utilize these short peptides and methods for their preparation.
Career Highlights
Søren Østergaard has been associated with Dako A/S, a company known for its advancements in diagnostic solutions. His work at Dako has allowed him to focus on innovative approaches to improve diagnostic methods in the medical field.
Collaborations
Søren Østergaard has collaborated with Marianne Jartved Mathiesen, contributing to the development of diagnostic methods and vaccines.
Conclusion
Søren Østergaard's contributions to the field of diagnostics, particularly through his patented methods, highlight his role as an innovator in medical technology. His work continues to impact the diagnosis and treatment of borreliosis, showcasing the importance of innovation in healthcare.